Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse model
- PMID: 32304142
- PMCID: PMC7552439
- DOI: 10.1096/fj.202000194R
Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse model
Abstract
Interindividual variability and sexual dimorphisms in the development of nonalcoholic fatty liver disease (NAFLD) are still poorly understood. In the present study, male and female strains of Collaborative Cross (CC) mice were fed a high-fat and high-sucrose (HF/HS) diet or a control diet for 12 weeks to investigate interindividual- and sex-specific variations in the development of NAFLD. The severity of liver steatosis varied between sexes and individual strains and was accompanied by an elevation of serum markers of insulin resistance, including increases in total cholesterol, low-density lipoproteins, high-density lipoproteins, phospholipids, and glucose. The development of NAFLD was associated with overexpression of the critical fatty acid uptake and de novo lipogenesis genes Pparg, Mogat1, Cd36, Acaab1, Fabp2, and Gdf15 in male and female mice. The expression of Pparg, Mogat1, and Cd36 was positively correlated with liver triglycerides in male mice, and Mogat1 and Cd36 expression were positively correlated with liver triglycerides in female mice. Our results indicate the value of CC mice in combination with HF/HS diet-induced alterations as an approach to study the susceptibility and interindividual variabilities in the pathogenesis of nonalcoholic fatty liver and early nonalcoholic steatohepatitis at the population level, uncovering of susceptible and resistant cohorts, and identifying sex-specific molecular determinants of disease susceptibility.
Keywords: Cd36; collaborative cross mice; gene expression; nonalcoholic fatty liver disease.
© 2020 Federation of American Societies for Experimental Biology.
Figures






References
-
- Younossi Z, Tacke F, Arrese M, Charma BC, Mostafa I, Bugianesi E, Wong VW-S, Yilmaz Y, George J, Fan J and Vow MB (2019) Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 69, 2672–2682. - PubMed
-
- Williams VF, Taubman SB and Stahlman S (2019) Non-alcoholic fatty liver disease (NAFLD), active component, U.S. Armed Forces, 2000–2017. MSMR 26, 2–11. - PubMed
-
- Younossi ZM (2019) Non-alcoholic fatty liver disease - A global public health perspective. J. Hepatol 70, 531–544. - PubMed
-
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L and Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73–84. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Molecular Biology Databases
Miscellaneous